SFShinsuke Fujii

Shinsuke Fujii

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shinsuke Fujii has a total of 82 co-authors. Here are the top co-authors by number of shared publications:

  • Tamotsu Kiyoshima

    Laboratory of Oral Pathology, Division of Maxillofacial Diagnostic and Surgical sciences, Faculty of Dental Science, Kyushu University, Fukuoka, Japan

    14 shared publications
  • Kana Hasegawa

    Laboratory of Oral Pathology, Division of Maxillofacial Diagnostic and Surgical sciences, Faculty of Dental Science, Kyushu University, Fukuoka, Japan

    10 shared publications
  • Yudai Tajiri

    Laboratory of Oral Pathology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan; Department of Dentistry and Oral Surgery, National Hospital Organization, Fukuokahigashi Medical Center, 1-1-1 Chidori, Koga, Fukuoka, 811-3195, Japan

    7 shared publications
  • Ryoko Nagano

    Laboratory of Oral Pathology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science Kyushu University Fukuoka Japan

    6 shared publications
  • Kari J. Kurppa

    Institute of Biomedicine and MediCity Research Laboratories, University of Turku, Turku, Finland

    5 shared publications
  • Shinji Matsumoto

    Department of Oral Physiology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan

    5 shared publications

Latest Publications

  • Open Access

    ARL4C in oral cancer cells promotes stromal RANKL expression via a RelA-dependent inflammatory axis in stromal fibroblasts

    by Thinh Thi Kim Truong, Shinsuke Fujii, Kana Hasegawa, Shinji Matsumoto, Kari J. Kurppa, Kristiina Heikinheimo, Julian Petersen, Aonan Li, Klaus Elenius, Eijiro Jimi, et al.

    Purpose: Jawbone destruction in oral squamous cell carcinoma (OSCC) is driven by receptor activator of nuclear factor-κB (NF-κB) ligand (RANKL)-mediated osteoclastogenesis. Although the cellular sources of RANKL and its regulatory mechanisms within the OSCC microenvironment remain elusive, this study aimed to elucidate how ADP-ribosylation factor-like 4 C (ARL4C), a key oncogene in oral cancer, promotes the pro-osteoclastogenic microenvironment by identifying the specific signaling axis responsible for RANKL induction in stromal fibroblasts. Methods: Stromal cells were cultured with OSCC-conditioned medium (CM), followed by comprehensive RNA sequencing and pathway enrichment analysis. Identified signaling pathways were validated using siRNA and pharmacological inhibitors. Spatial localization in human clinical specimens was evaluated by immunohistochemistry. Results: Transcriptomic profiling revealed significant enrichment of the NF-κB and Stat3 pathways in stromal cells exposed to OSCC-CM. Inhibition of RelA subunit (a major subunit of NF-κB) significantly reduced tumor-induced RANKL expression. We found that ARL4C expression in cancer cells promoted the secretion of proinflammatory cytokines, establishing a sustained RelA-mediated inflammatory response in stromal fibroblasts. Immunohistochemical analysis of human OSCC specimens confirmed that phosphorylated RelA and RANKL were co-expressed in α-SMA-positive stromal fibroblasts at the bone-invasive front, even in areas distant from tumor nests. Conclusions: This study identifies a tumor–stromal signaling axis where ARL4C in OSCC cells triggers a RelA-mediated inflammatory response in stromal fibroblasts. These fibroblasts act as a critical, non-canonical RANKL source driving jawbone destruction. Targeting the ARL4C–RelA axis might represent a promising therapeutic strategy for suppressing stromal RANKL expression and improving quality of life for OSCC patients.

  • Complement components C1r and C1s promote oral squamous cell carcinoma cell proliferation

    by Thinh Thi Kim Truong, Tatsufumi Fujimoto, Shinsuke Fujii, Kari J. Kurppa, Kana Hasegawa, Yudai Tajiri, Masafumi Moriyama, Tamotsu Kiyoshima


  • Open Access

    An ancient schwannoma with venous malformation-like features of the tongue: A case report and review of the literature

    by Tatsufumi Dds Fujimoto, Kana Dds Hasegawa, Wataru Dds Kumamaru, Toru Dds Chikui, Yuta Dds Yanai, Minami Dds Shibuya, Shinsuke Dds Fujii, Kazunori Dds Yoshiura, Shintaro Dds Kawano, Tamotsu Dds Kiyoshima

    Rationale: Composite lesions of neurogenic tumors with vascular malformations, which were once included among hemangiomas, are extremely rare and can be classified into 2 types: conjoined and discrete associations, with the former representing a single lesion of vascular malformation within tumor tissue. To date, we have found 24 composite lesions (conjoined association type) of schwannomas coexisting with vascular malformations. However, such composite lesions should be interpreted with caution. Patient concerns: A 29-year-old woman had recognized swelling of the tongue 5 years prior to her initial hospital visit and the lesion had recently been slowly growing. Diagnoses: Based on clinical examinations, including imaging studies, the tumorous lesion was clinically diagnosed as a schwannoma, but a benign salivary gland tumor and venous malformation (VM) were not completely ruled out. Interventions: The lesion was excised with safety margin. Outcomes: The excised sample revealed 2 intriguing features; however, the lesion was diagnosed as an ancient schwannoma with VM-like features because of the lack of definitive findings that would make these lesions a composite of independent lesions. There was no evidence of recurrence or distant metastasis at the 16-month follow-up after excision. Lessons: Ancient schwannomas of the oral cavity are rare. In particular, schwannomas that appear as composite lesions of schwannomas with vascular malformations are extremely rare. Here, we report the first case of an ancient schwannoma with VM-like features of the tongue. It is important for clinicians to accumulate information on these rare cases to make an accurate preoperative diagnosis and to plan appropriate treatment.


  • Open Access

    Oral metastatic tumor (renal cell carcinoma) in maxillary gingiva: A case report and systematic review

    by Yusuke Nakako, Tatsufumi Fujimoto, Hiroko Wada, Naoya Yoshihama, Yukiko Kami, Shinsuke Fujii, Kenichi Kohashi, Wataru Kumamaru, Toru Chikui, Masafumi Moriyama, et al.


  • Open Access

    Wnt/β-catenin-YAP axis in the pathogenesis of primary intraosseous carcinoma NOS, deriving from odontogenic keratocyst

    by Yusuke Nakako, Kana Hasegawa, Shinsuke Fujii, Yukiko Kami, Taiki Sakamoto, Mizuki Sakamoto, Masafumi Moriyama, Kari J. Kurppa, Kristiina Heikinheimo, Kazunori Yoshiura, et al.


  • Wnt/β-catenin-C-kit axis may play a role in adenoid cystic carcinoma prognostication

    by Shinsuke Fujii, Kana Hasegawa, Takashi Maehara, Kari J. Kurppa, Kristiina Heikinheimo, Kristy A. Warner, Satoshi Maruyama, Yudai Tajiri, Jacques E. Nör, Jun-Ichi Tanuma, et al.


  • The IL‐1β‐p65 axis stimulates quiescent odontogenic epithelial cell rests via TGF‐β signalling to promote cell proliferation of the lining epithelia in radicular cysts: A laboratory investigation

    by Ryoko Nagano, Yusuke Nakako, Shinsuke Fujii, Shintaro Kawano, Hidefumi Maeda, Tamotsu Kiyoshima

    Aim: Cyst formation of the jaws is frequently accompanied by the proliferation of odontogenic epithelial cells located in the periodontal ligament (PDL), which consists of heterozygous cells and includes the most fibroblasts. The lining epithelium of radicular cyst, an odontogenic cyst of inflammatory origin, is derived from the proliferation of the remnants of the Hertwig epithelial root sheath (odontogenic epithelial cell rests of Malassez; ERMs) in the PDL. ERMs are maintained at a lower proliferative state under physiological conditions, but the regulatory mechanisms underlying the inflammation‐dependent enhanced‐proliferative capabilities of ERMs are not fully understood. The aim of this study was to evaluate the effects of cytokine pathway association between TGF‐β signalling and IL‐1β signalling on the regulation of odontogenic epithelial cell proliferation using radicular cyst pathological specimens and odontogenic epithelial cell lines.Methodology: Immunofluorescence analyses were performed to clarify the expression levels of Smad2/3 and Ki‐67 in ERMs of 8‐week‐old mouse molar specimens. In radicular cyst (n = 52) and dentigerous cysts (n = 6) specimens from human patients, the expression of p65 (a main subunit of NF‐κB), Smad2/3 and Ki‐67 were investigated using immunohistochemical analyses. Odontogenic epithelial cells and PDL fibroblastic cells were co‐cultured with or without an inhibitor or siRNAs. Odontogenic epithelial cells were cultured with or without TGF‐β1 and IL‐1β. The proliferative capabilities and Smad2 phosphorylation levels of odontogenic epithelial cells were examined.Results: Immunohistochemically, Smad2/3‐positivity was increased, and p65‐positivity and Ki‐67‐positivity were decreased both in ERMs and in the epithelial cells in dentigerous cysts, a non‐inflammatory developmental cyst. In contrast, p65‐positive cells, along with the expression of Ki‐67, were increased and Smad2/3‐positive cells were decreased in the lining epithelia of radicular cysts. Co‐culture experiments with odontogenic epithelial cells and PDL fibroblastic cells revealed that PDL cells‐derived TGF‐β1/2 and their downstream signalling suppressed odontogenic epithelial cell proliferation. Moreover, TGF‐β1 stimulation induced Smad2 phosphorylation and suppressed odontogenic epithelial cell proliferation, while IL‐1β stimulation reversed these phenotypes through p65 transactivation.Conclusions: These results suggest that IL‐1β‐p65 signalling promotes odontogenic epithelial cell proliferation through suppressing TGF‐β‐Smad2 signalling, which would be involved in the pathogenesis of radicular cysts.


  • Arl4c is involved in tooth germ development through osteoblastic/ameloblastic differentiation

    by Thinh Thi Kim Truong, Shinsuke Fujii, Ryoko Nagano, Kana Hasegawa, Megumi Kokura, Yuta Chiba, Keigo Yoshizaki, Satoshi Fukumoto, Tamotsu Kiyoshima


  • The role of Wnt, ARL4C, and Sema3A in developmental process and disease pathogenesis

    by Shinsuke Fujii, Tamotsu Kiyoshima

    Various types of tumors, including malignant and benign ones, occur in the oral cavity. These arise from the mucosal epithelium, odontogenic epithelium, and salivary gland. To date, few major driver events in oral tumors have been identified. Accordingly, molecular targets in anti‐tumor therapy for oral tumors are lacking. We focused on elucidating the function of aberrantly activated signal transduction related to oral tumor formation, especially in oral squamous cell carcinoma, ameloblastoma, and adenoid cystic carcinoma, which are raised as common oral tumors. Wnt/β‐catenin‐dependent pathway is involved in the developmental process, organ homeostasis and disease pathogenesis through regulating various cellular functions by enhancing transcriptional activity. Recently, we identified ADP‐ribosylation factor (ARF)‐like 4c (ARL4C) and Semaphorin 3A (Sema3A), the expression of which is regulated by Wnt/β‐catenin‐dependent pathway, and characterized their functions in the developmental process and tumor formation. This review highlights the recent advances in understanding the roles of Wnt/β‐catenin‐dependent pathway, ARL4C and Sema3A, as determined by pathological and experimental studies.


  • Stepwise activation of p63 and the MEK/ERK pathway induces the expression of ARL4C to promote oral squamous cell carcinoma cell proliferation

    by Dania Zuhier Ragheb Alkhatib, Thinh Thi Kim Truong, Shinsuke Fujii, Kana Hasegawa, Ryoko Nagano, Yudai Tajiri, Tamotsu Kiyoshima